Home > Boards > US Listed > Biotechs > BrainStorm Cell Therapeutics Inc. (BCLI)

https://philadelphia.cbslocal.com/2019/03/11/als-patients-fighting-fda-for-experimental-drug-nurown/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
condoe3 Member Profile
 
Followed By 1
Posts 634
Boards Moderated 0
Alias Born 02/02/12
160x600 placeholder
BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled GlobeNewswire Inc. - 10/11/2019 1:00:00 AM
BrainStorm Announces Notice of US Patent Allowance for NurOwn® Cellular Therapeutic Technology Platform GlobeNewswire Inc. - 10/7/2019 8:04:26 AM
BrainStorm Cell Therapeutics to Present NurOwn® Phase 2 Biomarker Data at North East Amyotrophic Lateral Sclerosis (NEALS) 1... GlobeNewswire Inc. - 10/2/2019 6:45:00 AM
BrainStorm Cell Therapeutics Announces Support for FDA Guidelines on ALS Drug Development GlobeNewswire Inc. - 9/27/2019 4:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 8:01:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 8:01:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/9/2019 8:01:03 AM
BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financi... GlobeNewswire Inc. - 9/9/2019 1:00:00 AM
BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress GlobeNewswire Inc. - 9/6/2019 1:50:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/3/2019 6:01:01 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2019 5:03:19 PM
Prospectus Filed Pursuant to Rule 424(b)(1) (424b1) Edgar (US Regulatory) - 8/30/2019 5:02:28 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/16/2019 5:18:25 PM
BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update GlobeNewswire Inc. - 8/13/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 6:05:47 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/9/2019 5:10:20 PM
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Comprehensive Corporate Update GlobeNewswire Inc. - 8/5/2019 1:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/2/2019 5:02:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/2/2019 9:30:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/26/2019 5:04:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2019 5:04:06 PM
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study GlobeNewswire Inc. - 7/2/2019 8:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2019 5:03:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/11/2019 5:03:07 PM
BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting GlobeNewswire Inc. - 5/31/2019 1:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist